Despite the intrinsic resistance of tamoxifen-induced melanomas to Brafi, Brafi promotes a proinflammatory TME, as evidenced by increased tumor Ag expression, TIL recruitment, local production of IFNγ and decreasing immune suppression.5–8 We therefore examined whether Brafi-resistant tumors would respond to skin immunization. Here, IFNG is linked to neoplasm.